Patents by Inventor Beate Schmidt

Beate Schmidt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
    Patent number: 7423046
    Abstract: Compounds of formula (I), in which R1, R2, R3, R4, R5, R6 and R7 have the meaning indicated in the description, are novel effective PDE4 inhibitors.
    Type: Grant
    Filed: August 29, 2003
    Date of Patent: September 9, 2008
    Assignee: Nycomed GmbH
    Inventors: Ulrich Kautz, Beate Schmidt
  • Roflumilast for the Treatment of Diabetes Mellitus
    Publication number: 20080214625
    Abstract: The invention relates to the use of Roflumilast and/or Roflumilast N-Oxide for the treatment of diabetes mellitus and accompanying disorders thereof. The invention additionally relates to combinations of Roflumilast and/or Roflumilast N-Oxide with other active agents for the treatment of diabetes mellitus.
    Type: Application
    Filed: March 3, 2006
    Publication date: September 4, 2008
    Applicant: KONINKLIJKE HILIPS ELECTRONICS, N.V.
    Inventors: Hans-Peter Kley, Guido Hanauer, Daniela Hauser, Beate Schmidt, Dirk Bredenbroker, Wilhelm Wurst, Jorg Kemkowski
  • Amido-Substituted 6-Phenylphenanthridines
    Publication number: 20080214536
    Abstract: Compounds of a certain formula (I) in which R1, R2, R3, R31, R4, R5, R51, R6 and R7 have the meanings indicated in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: March 9, 2006
    Publication date: September 4, 2008
    Applicant: NYCOMED Gmbh
    Inventors: Ulrich Kautz, Beate Schmidt, Dieter Flockerzi, Maria Vittoria Chiesa, Armin Hatzelmann, Christof Zitt, Johannes Barsig, Degenhard Marx, Hans-Peter Kley
  • 6-Heteroaryl-1,2,3,4,4A, 10B-Hexahydrophenanthridines as Pde4-Inhibitors for the Treatment of Inflammatory Disorders
    Publication number: 20080167316
    Abstract: Compounds of a certain formula I in which R1, R2, R3, R31, R4, R5, R51 and Har have the meanings indicated in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: March 1, 2006
    Publication date: July 10, 2008
    Applicant: Altana Pharma AG
    Inventors: Ulrich Kautz, Beate Schmidt, Dieter Flockerzi, Maria Vittoria Chiesa, Armin Hatzelmann, Christof Zitt, Adrea Wohlsen, Degenhard Marx, Hans-Peter Kley
  • Novel 6-Pyridylphenanthridines
    Publication number: 20080119505
    Abstract: Compounds of a certain formula (I), in which R1, R2, R3, R31, R4, R5, R51 and Har have the meanings indicated in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: January 31, 2006
    Publication date: May 22, 2008
    Applicant: ALTANA Pharma AG
    Inventors: Ulrich Kautz, Beate Schmidt, Dieter Flockerzi, Maria Vittoria Chiesa, Armin Hatzelmann, Christof Zitt, Johannes Barsig, Andrea Wohlsen, Degenhard Marx, Hans-Peter Kley
  • 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
    Patent number: 7329676
    Abstract: The compounds of formula I in which R1, R2, R3, R31, R4, R5, R6 and R7 have the meanings as indicated in the description, are novel effective PDE4 inhibitors.
    Type: Grant
    Filed: August 28, 2003
    Date of Patent: February 12, 2008
    Assignee: Nycomed GmbH
    Inventors: Ulrich Kautz, Beate Schmidt
  • Phthalazinone-piperidino-derivatives as PDE4 inhibitors
    Publication number: 20070129373
    Abstract: The compounds of formula I in which the given substituents have the meanings as given in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: December 29, 2006
    Publication date: June 7, 2007
    Inventors: Gerhard Grundler, Beate Schmidt, Geert Sterk
  • Phthalazinone-piperidino-derivatives as PDE4 inhibitors
    Patent number: 7179810
    Abstract: The compounds of formula I in which the given substituents have the meanings as given in the description, are novel effective PDE4 inhibitors.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: February 20, 2007
    Assignee: Altana Pharma AG
    Inventors: Gerhard Grundler, Beate Schmidt, Geert Jan Sterk
  • Novel 6-phenylphenantridines
    Publication number: 20060189645
    Abstract: Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51, R6, R7 and R8 have the meanings indicated in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: July 30, 2004
    Publication date: August 24, 2006
    Applicant: Altana Pharma AG
    Inventor: Beate Schmidt
  • Novel 6-phenlyphenanthridines
    Publication number: 20060189641
    Abstract: Compounds of a certain formula (I) in which R1, R2, R3, R31, R4, R5, R51, R6, R7 and R8 have the meanings indicated in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: July 30, 2004
    Publication date: August 24, 2006
    Inventor: Beate Schmidt
  • Nitrate esters of phenylaminothiophenacetic acid derivatives
    Publication number: 20060167082
    Abstract: The compounds of formula I in which R1, R2, R3, R4 and R5 have the meanings as given in the description are novel effective antiinflammatory compounds.
    Type: Application
    Filed: February 17, 2004
    Publication date: July 27, 2006
    Inventor: Beate Schmidt
  • Process for preparing crystalline ciclesonide with defined particle size
    Publication number: 20060128954
    Abstract: The invention relates to a novel process for preparing crystalline ciclesonide with an advantageous particle size and to the use for producing pharmaceutical preparations, in particular for topical use. The crystalline ciclesonide obtained by the novel process has advantageous aerodynamic properties, and can be further processed to inhalable or nasally administered pharmaceutical preparations without further mechanical micronization.
    Type: Application
    Filed: March 26, 2004
    Publication date: June 15, 2006
    Applicant: Altana Pharma AG
    Inventor: Beate Schmidt
  • Novel phenanthridines
    Publication number: 20060116518
    Abstract: Compounds of a certain formula 1, in which R1, R2, R3, R31, R4, R5, R51, R6 and R7 have the meanings indicated in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: August 13, 2003
    Publication date: June 1, 2006
    Applicant: Altana Pharma AG
    Inventors: Dieter Flockerzi, Beate Schmidt, Steffen Weinbrenner
  • Piperazino-derivatives and their use as PDE4 inhibitor
    Patent number: 7022696
    Abstract: The compounds of formula I in which R1, R2, R3, A, X, s and R9 have the meanings as given in the description are novel effective PDE4 inhibitors.
    Type: Grant
    Filed: April 24, 2002
    Date of Patent: April 4, 2006
    Assignee: Altana Pharma AG
    Inventors: Gerhard Grundler, Beate Schmidt, Geert Jan Sterk
  • 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
    Publication number: 20050239817
    Abstract: The compounds of formula I in which R1, R2, R3, R31, R4, R5, R6 and R7 have the meanings as indicated in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: August 28, 2003
    Publication date: October 27, 2005
    Applicant: Altana Pharma AG
    Inventors: Ulrich Kautz, Beate Schmidt
  • Phthalazinone-piperidino-derivatives as PDE4 inhibitors
    Publication number: 20050234062
    Abstract: The compounds of formula I in which the given substituents have the meanings as given in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: June 3, 2005
    Publication date: October 20, 2005
    Inventors: Gerhard Grundler, Beate Schmidt, Geert Sterk
  • Phthalazinone-piperidino-derivatives as PDE4 inhibitors
    Patent number: 6953853
    Abstract: The compounds of a formula I, in which the given substituents have the meanings as given in the description, are novel effective PDE4 inhibitors
    Type: Grant
    Filed: February 14, 2002
    Date of Patent: October 11, 2005
    Assignee: Altana Pharma AG
    Inventors: Gerhard Grundler, Beate Schmidt, Geert Jan Sterk
  • 6-heteroarylphenanthridines
    Patent number: 6884802
    Abstract: Compounds of formula 1, in which Het is an unsubstituted or R6- and/or R7-substituted pyrrolyl, furanyl, thiophenyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrimidinyl, pyrazinyl or pyradazinyl radical, or an unsubstituted or R6- and/or R7-substituted fused bi- or tricyclic ring system comprising at least one aromatic ring and up to 4 heteroatoms-selected from the group consisting of O (oxygen), S (sulfur), N (nitrogen)- which is bonded to the phenanthridinyl radical via one of the rings comprising one or more heteroatoms, are active PDE4 inhibitors.
    Type: Grant
    Filed: July 7, 2001
    Date of Patent: April 26, 2005
    Assignee: ALTANA Pharma AG
    Inventor: Beate Schmidt
  • Process for the production of 16,17-[{cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation
    Publication number: 20050080063
    Abstract: The invention relates to a process for the preparation of 16,17-[(cyclohexylmethylene)bis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione[11?,16?(R)] and similar compounds, by reaction of an appropriate 16,17-ketal with cyclohexanealdehyde.
    Type: Application
    Filed: November 6, 2001
    Publication date: April 14, 2005
    Inventor: Beate Schmidt
  • (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitors
    Patent number: 6818651
    Abstract: 3,4-Dihydroisoquinoline and isoquinoline compounds of formula I, in which Ar represents a phenyl raidcal of the formulae IIa, IIb or IIc are novel effective PDE7 inhibitors.
    Type: Grant
    Filed: August 21, 2003
    Date of Patent: November 16, 2004
    Assignee: Altana Pharma AG
    Inventors: Steffen Weinbrenner, Beate Schmidt, Gerhard Grundler, Josef Stadlwieser, Armin Hatzelmann, Geert Jan Sterk